ARLINGTON, VA-April 5, 2005-On Monday Tamara Zemlo, Ph.D., MPH, Executive Director of The Science Advisory Board, presented an overview of RNA interference research opportunities at the Emerging Technologies for Drug Discovery Meeting in San Francisco, CA. Her talk, “RNA Interference Technology: Challenges and Opportunities,” provided life science researchers with insights into the types of products and services required to support functional genomics research, and was based upon a survey conducted by BioInformatics, LLC (http://www.gene2drug.com), an Arlington, VA-based market research and consulting firm.
